株式会社極東書店トップ ＞ 商品一覧 ＞ Conflict of Interest and Medicine : Knowledge, Practices, and Mobilizations.
商品詳細
Conflict of Interest and Medicine : Knowledge, Practices, and Mobilizations.
・ISBN 978-0-367-75115-9 2021 hard GB£ 171.99
￥54,486.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
・ISBN 978-0-367-75117-3 2023 paper GB£ 46.99
￥14,886.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
電子版あり 大学・学術機関向け電子ブック（eBook）ISBN 978-1-003-16103-5
| 著者・編者 | Hauray, Boris / Boullier, Henri et al. (eds.), |
|---|---|
| 出版社 | (Routledge, UK) |
| 出版年月 | 2021.09 |
| ページ数 | 252 pp. |
| 言語 | ENG |
| ニュース番号 | ＜663-L788 663-P1201＞ |
解説
In the context of a growing criticism on the influence of the pharmaceutical industry on physicians, scientists, or politicians, Conflict of Interest and Medicine offers a comprehensive analysis of the conflict of interest in medicine anchored in the social sciences, with perspectives from sociology, history, political science, and law.
Based on in-depth empirical investigations conducted within different territories (France, the European Union, and the United States) the contributions analyze the development of conflict of interest as a social issue and how it impacts the production of medical knowledge and expertise, physicians' work and their prescriptions, and also the framing of health crises and controversies. In doing so, they bring a new understanding of the transformations in the political economy of pharmaceutical knowledge, the politicization of public health risks, and the promotion of transparency in science and public life.
Complementing the more normative and quantitative understandings of conflict of interest issues that dominate today, this book will be of interest to researchers in a broad range of areas including social studies of sciences and technology, sociology of health and illness, and political sociology and ethics. It will be also a valuable resource for health professionals, medical scientists, or regulators facing the question of corporate influence.